Paion AG (LTS:0NF3)
€ 0.03 0 (0%) Market Cap: 62,000.00 Enterprise Value: 16.66 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 41/100

Paion AG - Special Call Transcript

Jan 13, 2021 / 01:00PM GMT
Release Date Price: €25.13 (+0.93%)
Operator

Welcome to the PAION AG conference call on the licensing agreement with La Jolla Pharmaceutical for GIAPREZA and XERAVA in Europe.

The call is hosted by Dr. Jim Phillips; as well as Abdelghani Omari.

I will now hand over to Ralf Penner to begin. Thank you.

Ralf Penner
Paion AG - VP of IR & Public Relations

Thank you very much for your kind introduction. Dear, ladies and gentlemen, thank you very much for joining us for today's conference call. My name is Ralf Penner. I am PAION's Vice President of Investor Relations, and I'll be moderating today's call.

I'm joined by Dr. Jim Phillips, PAION's CEO; as well as Abdelghani Omari, our CFO.

Within the next half hour, we are going to explain the details of the licensing agreement signed yesterday with La Jolla for the 2 products, GIAPREZA and XERAVA. After this initial presentation, we'll be happy to take your questions.

I would like to point out that the slides for the presentation can be accessed via webcast in parallel to this conference call and the webcast

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot